Giorgia Guglielmi

Gut fungi may be linked to inflammation in severe COVID

The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.

‘Hidden’ bacteria could explain recurrent urinary tract infections

The findings of a recent study indicate that effective treatments for recurrent UTIs may require the ability to penetrate human tissues.

Immune responses to gut microbes may indicate who benefits from diabetes therapy

The findings of a recent study indicate that antibodies to gut microbes could help identify who may benefit from teplizumab.

Some gut microbes are linked to negative clinical outcomes in people with HIV

The findings of a recent study suggest that the conversion of dietary fiber or lactate to SCFAs influences comorbidity risk associated with HIV.

Fecal microbiota transplants may help fight ‘superbugs’

The findings of a recent study suggest that fecal microbiota transplants reduce colonization with multidrug-resistant organisms in people who received kidney transplants.

Antibiotics alter the gut microbiota in ways that disrupt responses to immunotherapy

The findings of a recent study suggest that antibiotics should be prescribed with caution in cancer patients who are planning to receive PD-1 inhibitors.

Lung bacteria may be associated with brain conditions after severe pneumonia

By suggesting that the bacteria detected in the brain after severe pneumonia originate from the lungs, the findings shed light onto the mechanisms of pneumonia-induced neurological conditions.

Skin microbes may influence the outcome of leishmaniasis

The findings of a recent study may inform new therapies to modulate the skin microbiota in people with leishmaniasis.

The gut microbiota is linked to bloodstream infection in critically ill patients

The findings of a recent study link the gut microbiota and the microorganisms responsible for bloodstream infection in critically ill patients.

Microbiota signature may predict severe outcome of SARS-CoV-2 infection

The findings of a recent study suggest that, during SARS-CoV-2 infection, some bacteria in the upper airways’ microbiota may be associated with a person’s disease progression to intubation.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top